133 related articles for article (PubMed ID: 34793919)
21. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
Avgoustakis K
Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
[TBL] [Abstract][Full Text] [Related]
22. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
[TBL] [Abstract][Full Text] [Related]
23. Tumor targetable and pH-sensitive polymer nanoparticles for simultaneously improve the Type 2 Diabetes Mellitus and malignant breast cancer.
Tang S; Wen P; Li K; Deng J; Yang B
Bioengineered; 2022 Apr; 13(4):9754-9765. PubMed ID: 35411835
[TBL] [Abstract][Full Text] [Related]
24. Eudragit L-100 Capsules Aromatize and Quaternerize Chitosan for Insulin Nanoparticle Oral Delivery During Toxic Oxidative Stress in Rat Liver and Kidney.
Mahjub R; Najafabadi FK; Dehkhodaei N; Kheiripour N; Ahmadabadi AN; Asl SS; Taheri-Azandariani M; Ranjbar A
Pharm Nanotechnol; 2020; 8(3):239-254. PubMed ID: 32600243
[TBL] [Abstract][Full Text] [Related]
25. Nanoscale cationic micelles of amphiphilic copolymers based on star-shaped PLGA and PEI cross-linked PEG for protein delivery application.
Wang J; Li S; Chen T; Xian W; Zhang H; Wu L; Zhu W; Zeng Q
J Mater Sci Mater Med; 2019 Aug; 30(8):93. PubMed ID: 31392433
[TBL] [Abstract][Full Text] [Related]
26. A strategy for developing effective orally-delivered nanoparticles through modulation of the surface "hydrophilicity/hydrophobicity balance".
Cui Y; Shan W; Liu M; Wu L; Huang Y
J Mater Chem B; 2017 Feb; 5(6):1302-1314. PubMed ID: 32263598
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of hydroxyapatite nanoparticles carrying insulin and gallic acid for insulin oral delivery.
Zhang Y; Zhang L; Ban Q; Li J; Li CH; Guan YQ
Nanomedicine; 2018 Feb; 14(2):353-364. PubMed ID: 29157980
[TBL] [Abstract][Full Text] [Related]
28. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
[TBL] [Abstract][Full Text] [Related]
29. Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration.
Wu L; Liu M; Shan W; Cui Y; Zhang Z; Huang Y
Int J Pharm; 2017 Mar; 520(1-2):216-227. PubMed ID: 28185960
[TBL] [Abstract][Full Text] [Related]
30. Thiolated Nanoparticles Overcome the Mucus Barrier and Epithelial Barrier for Oral Delivery of Insulin.
Zhou S; Deng H; Zhang Y; Wu P; He B; Dai W; Zhang H; Zhang Q; Zhao R; Wang X
Mol Pharm; 2020 Jan; 17(1):239-250. PubMed ID: 31800258
[TBL] [Abstract][Full Text] [Related]
31. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.
Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M
Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176
[TBL] [Abstract][Full Text] [Related]
33. Design and in vitro/in vivo Evaluation of Polyelectrolyte Complex Nanoparticles Filled in Enteric-Coated Capsules for Oral Delivery of Insulin.
Arpaç B; Devrim Gökberk B; Küçüktürkmen B; Özakca Gündüz I; Palabıyık İM; Bozkır A
J Pharm Sci; 2023 Mar; 112(3):718-730. PubMed ID: 36150470
[TBL] [Abstract][Full Text] [Related]
34. Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin.
Zhang P; Xu Y; Zhu X; Huang Y
Int J Pharm; 2015 Dec; 496(2):993-1005. PubMed ID: 26541299
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems.
Bai Y; Zhou R; Wu L; Zheng Y; Liu X; Wu R; Li X; Huang Y
J Mater Chem B; 2020 Apr; 8(13):2636-2649. PubMed ID: 32129375
[TBL] [Abstract][Full Text] [Related]
36. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
Jain S; Rathi VV; Jain AK; Das M; Godugu C
Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
[TBL] [Abstract][Full Text] [Related]
37. Preparation, in vitro and in vivo evaluation of PLGA/Chitosan based nano-complex as a novel insulin delivery formulation.
Mohammadpour F; Hadizadeh F; Tafaghodi M; Sadri K; Mohammadpour AH; Kalani MR; Gholami L; Mahmoudi A; Chamani J
Int J Pharm; 2019 Dec; 572():118710. PubMed ID: 31629731
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
[TBL] [Abstract][Full Text] [Related]
39. Preparation and evaluation of PEG-coated zein nanoparticles for oral drug delivery purposes.
Reboredo C; González-Navarro CJ; Martínez-Oharriz C; Martínez-López AL; Irache JM
Int J Pharm; 2021 Mar; 597():120287. PubMed ID: 33524523
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional Composite Microcapsules for Oral Delivery of Insulin.
Sun S; Liang N; Gong X; An W; Kawashima Y; Cui F; Yan P
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
